Limd1 Antibodies

Santa Cruz Biotechnology offers a broad range of Limd1 monoclonal antibodies for research focused on understanding Lim domain-containing protein 1 (Limd1). Limd1 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Limd1 is a crucial protein involved in cellular processes such as cell adhesion, migration, and proliferation. Research has shown that Limd1 functions as a tumor suppressor and has been implicated in various cancers. Understanding Limd1 function can provide insights into the mechanisms of tumorigenesis and potential therapeutic strategies. Limd1 Antibodies enable precise detection and analysis of Limd1 expression patterns in different tissues and cell types. Researchers can investigate Limd1's role in both normal physiological conditions and disease states. Advanced research techniques supported by Limd1 monoclonal antibodies allow for detailed examination of protein interactions and signaling pathways. Santa Cruz Biotechnology monoclonal antibodies for Limd1 research contribute to advancing scientific understanding of cancer biology and therapeutic development.